| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | Chief Executive Officer
2 companies
Gibson Christopher is a Director at RECURSION PHARMACEUTICALS, INC. with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 58 sells.
Estimated insider holdings value: $3.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 5, 2023 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sell | 21,000 | $7.39 | $155,131.10 | -3.8% | -12.5% | +61.9% | |
| Dec 1, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 39,710 | $9.04 | $358,946.95 | -3.3% | -14.5% | -20.5% | |
| Nov 3, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 39,193 | $10.01 | $392,200.33 | -3.3% | -14.9% | -41.2% | |
| Oct 6, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 38,553 | $11.58 | $446,573.57 | -3.3% | -33.3% | -40.0% | |
| Sep 1, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 39,066 | $10.35 | $404,199.05 | -3.4% | -13.6% | -16.2% | |
| Aug 4, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 39,325 | $9.49 | $373,057.57 | -3.5% | +7.9% | +29.2% | |
| Jul 7, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 39,614 | $9.05 | $358,647.23 | -3.6% | +29.1% | -23.7% | |
| Jun 2, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 42,190 | $6.11 | $257,624.90 | -3.9% | +61.9% | +26.8% | |
| May 5, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 55,330 | $6.47 | $357,900.45 | -3.5% | +51.6% | -20.0% | |
| Apr 29, 2022 | RXRX Recursion Pharmaceuticals, Inc. | Chief Executive Officer | Sale+OE | 80,675 | $6.14 | $495,381.25 | -4.0% | +33.4% | -23.1% |